Bell Potter

We recap some of the profit reporting season highlights from the past week including Bionomics, Medical Developments International, Accent Group, Altium and WiseTech Global. Full reports are available below via links. Show More

Mathan Somasundaram

Whilst global markets have maintained positive momentum into 2017, valuations look stretched. Markets are going to run into the US reporting season given the US leadership change and the recent rally pricing due to the optimistic outlook. However, US fiscal policy uncertainty, historically low volatility, rising USD, rising yields and... Show More

Stuart Roberts

Ever had a bad accident where the ambulance arrived and the medics gave you the ‘the green whistle’? After a few puffs, you got rapid pain relief, right? What they gave you was methoxyflurane. It isn't one of those dangerous opioids, simply a 'halogenated ether' that has been around for... Show More

Livewire Exclusive

For the first three months of 2016 the ASX 200 has delivered a negative 4% return. Weakness in the major index constituents continues to weigh on many investor portfolios. However, there remains a subset of companies that continue to thrive - delivering opportunity for the active investor. Livewire reached out... Show More

Mark Newman

For those unfortunate enough to have had a painful injury, you would be familiar with ‘the green whistle’ administered by medics which, after a few puffs, provides instant pain relief. This product is manufactured in Melbourne by Medical Developments (MVP) and has been used by hospitals, ambulances, defense forces, national... Show More

Wilson Asset Management

Medical Developments International (ASX: MVP) announced this week it received final approval from the Health Products Regulatory Authority of the Republic of Ireland to market and sell its inhaled pain-relief product Penthrox. The company said the approval gives MVP’s partner in Ireland and the United Kingdom, Galen, the opportunity to... Show More

Wilson Asset Management

Medical device manufacturer Medical Developments International (ASX:MVP) has received regulatory approval from the Health Sciences Authority in Singapore to market and sell Penthrox. MVP is the only global supplier of Penthrox, an emergency pain relief device developed in Australia and commonly known as “the green whistle”. The approval follows the... Show More